Lundbeck to buy Longboard Pharma in US$2.6 billion deal
Lundbeck is offering shareholders in the US company Longboard US$60 per share in cashH Lundbeck agreed to acquire Longboard Pharmaceuticals ...
Lundbeck is offering shareholders in the US company Longboard US$60 per share in cashH Lundbeck agreed to acquire Longboard Pharmaceuticals ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.